HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cécile Pautas Selected Research

Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)

6/2015Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cécile Pautas Research Topics

Disease

22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 05/2009
9Leukemia
01/2020 - 10/2007
6Infections
01/2020 - 01/2005
3Graft vs Host Disease (Graft-Versus-Host Disease)
11/2020 - 11/2008
3Residual Neoplasm
03/2016 - 03/2013
3Mycoses (Diseases, Fungus)
02/2011 - 04/2009
2Toxoplasmosis
12/2019 - 01/2005
2Thrombocytopenia (Thrombopenia)
01/2019 - 04/2012
2Hematologic Neoplasms (Hematological Malignancy)
12/2017 - 04/2009
2Invasive Fungal Infections
04/2009 - 02/2008
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2021
1Measles
01/2020
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2019
1Febrile Neutropenia
10/2018
1Agranulocytosis (Granulocytopenia)
01/2018
1Autoimmune Lymphoproliferative Syndrome
01/2018
1Carcinoma (Carcinomatosis)
01/2018
1Multiple Myeloma
12/2017
1Lymphopenia (Lymphocytopenia)
06/2016
1Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
04/2016
1Hemolytic Anemia
07/2015
1Hodgkin Disease (Hodgkin's Disease)
09/2013
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
05/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2011
1Pathologic Complete Response
06/2011
1Blast Crisis (Blast Phase)
06/2011
1Glioma (Gliomas)
08/2010
1Chromosome Aberrations (Chromosome Abnormalities)
05/2009
1Neoplasms (Cancer)
11/2008

Drug/Important Bio-Agent (IBA)

8Gemtuzumab (Mylotarg)FDA Link
01/2021 - 01/2012
3Core Binding Factors (Core-Binding Factor)IBA
06/2015 - 03/2013
3Daunorubicin (Cerubidine)FDA LinkGeneric
01/2013 - 06/2011
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2012 - 06/2011
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 08/2010
2DNA (Deoxyribonucleic Acid)IBA
07/2015 - 01/2005
1Conjugate VaccinesIBA
11/2020
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
11/2020
1VaccinesIBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
12/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2018
1Bortezomib (Velcade)FDA Link
12/2017
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
06/2016
1Peroxidase (Myeloperoxidase)IBA
04/2016
1Histocompatibility Antigens Class IIIBA
02/2016
1AntibodiesIBA
02/2016
1Viral AntibodiesIBA
07/2015
1Immunoglobulin M (IgM)IBA
07/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2015
1Transcription Factors (Transcription Factor)IBA
06/2015
1Dasatinib (BMS 354825)FDA Link
06/2015
1alpha-hydroxyglutarateIBA
02/2014
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2013
1trans-sodium crocetinate (crocetin)IBA
08/2011
1Imatinib Mesylate (Gleevec)FDA Link
06/2011
1Tyrosine Kinase InhibitorsIBA
06/2011
1Protein Isoforms (Isoforms)IBA
08/2010
1EnzymesIBA
08/2010
1fms-Like Tyrosine Kinase 3IBA
05/2009
1CCAAT-Enhancer-Binding Protein-alphaIBA
05/2009
1galactomannanIBA
04/2009
1AntigensIBA
04/2009
1liposomal amphotericin BFDA Link
02/2008

Therapy/Procedure

11Therapeutics
01/2021 - 01/2005
11Drug Therapy (Chemotherapy)
01/2021 - 02/2011
6Stem Cell Transplantation
01/2021 - 01/2005
5Hematopoietic Stem Cell Transplantation
01/2021 - 12/2017
4Cell Transplantation
01/2020 - 05/2012
2Transplantation
01/2020 - 01/2005
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2013
1Salvage Therapy
06/2012
1Induction Chemotherapy
06/2011